All Articles

StimLabs secures FDA clearance for Theracor, the first-ever umbilical cord sheet device, offering new hope for patients with hard-to-heal chronic wounds.

Chegg repurchases convertible notes at a discount, a calculated move to strengthen its finances as it pivots to the competitive skilling market.

Finnish tech firm Bittium secures a landmark €120M licensing deal with Spain's Indra, boosting its finances and enabling sovereign defense technology.

Facing soaring demand, AI robotics firm TechForce is seeking a global manufacturing partner, signaling a major shift from pilot programs to mass production.

INOVIO's promising non-surgical treatment for a rare disease faces FDA scrutiny, casting doubt on its fast-track approval and impacting patient hopes.

OWC is set to debut a suite of next-gen Thunderbolt 5 hardware and a disruptive software platform, promising to supercharge creative workflows.

The AI investment frenzy is shifting from GPUs to the physical world of power, cooling, and real estate, creating a new class of high-value companies.

With $13.2 billion in assets and 3.41% of all ETH, Bitmine is on a quest for market dominance. A crucial shareholder vote will decide its future.

With a new CEO and a booming market, mobile care provider instED is poised for major expansion. Here's what the move means for the future of healthcare.

A new report reveals the staggering personal cost of financial illiteracy is $948 per person, totaling over $246 billion for the nation in 2025.

SoftBank is buying digital infrastructure giant DigitalBridge for $4B, a bold move to own the data centers and fiber needed to power its AI ambitions.

Purina Foundation's 2025 grants extend beyond animal welfare, funding disaster relief, youth education, and veteran support in a strategic philanthropic push.

Syntiant unveils ultra-thin AI chips for hearables and smart remotes, aiming to dominate the booming market for miniaturized intelligent devices.

A Korean pet food brand's surprise win over tech giants at a top pitch event signals a major shift in what venture capitalists value. Here's why.

Genmab discontinues its 'encouraging' lung cancer drug, acasunlimab, in a bold strategic pivot to accelerate its most promising late-stage assets.

A chiropractor with millions of followers claims he can reverse dementia. As science eyes a breakthrough, we examine the hope, the hype, and the business.

A Chinese manufacturer is solving a global branding puzzle, merging bespoke craftsmanship with industrial scale through a unique 'MaaS' production model.

In a move to protect shareholders, IP Strategy canceled a dilutive financing deal, signaling deep confidence in its $IP token reserves and the Story ecosystem.

Professional Diversity Network invests millions in an AI crypto token, a risky move signaling a dramatic pivot into the volatile world of Web3 finance.

Alico pivots from its 125-year citrus legacy to land development, and its CEO is set to face investors with a bold new plan for its 50,000 acres.